Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III [Phase 3]
A Phase 3 clinical trial evaluating positron emission tomography for follow-up in stage II/III colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer [Phase 2]
Phase 2 trial update evaluating standard- and high-dose irinotecan guided by UGT1A1 genotype for first-line treatment of locally advanced co…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial investigating celecoxib, capecitabine, and irinotecan in recurrent or metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: CyberKnife® for Hepatic Metastases From Colorectal Cancer [Phase 2]
Phase 2 trial of CyberKnife for liver metastases from colorectal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
A clinical trial update discusses skin biopsies and DNA analysis in patients receiving irinotecan or gemcitabine for advanced solid tumors; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy [Phase 3]
A Phase 3 clinical trial comparing lubiprostone with PEG bowel prep versus conventional PEG prep for colonoscopy has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed [Phase 3]
A Phase 3 trial update evaluating chemotherapy plus radiation therapy after surgical removal of rectal cancer (SWOG-9304) has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
This update reports the completion of a Phase 2 trial evaluating Bryostatin 1 in patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS withdrawal · 2013-04-05Clinical Trial Update: Prospective Trial of Metformin - Chemoprevention Role [NA]
A trial studying metformin for colorectal cancer chemoprevention has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Immunoreactivity to Cetuximab in Cancer Patients
This completed clinical trial evaluated immunoreactivity to cetuximab in patients with colorectal cancer and head and neck cancer.
-
FDA label_change · 2013-03-28FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for VECTIBIX (panitumumab) filed by Amgen, Inc. The approval updates the drug's labeling to reflect …
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
A clinical trial evaluating Avastin (bevacizumab) in combination with chemotherapy for metastatic or advanced unresectable colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating GTI-2040 in combination with oxaliplatin and capecitabine for locally advanced or metastatic colorectal ca…
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery [Phase 3]
Phase 3 trial evaluating whether calcium gluconate and magnesium sulfate can prevent oxaliplatin-induced neurotoxicity in patients with colo…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer [NA]
This clinical trial update compares barium enema, CT colonography, and colonoscopy for detecting colon cancer. The study, conducted at Duke …
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer [Phase 1]
Phase 1 study evaluating ZD 1839 (gefitinib) in combination with chemotherapy for locally advanced, locally recurrent, or metastatic colorec…
-
CLINICAL_TRIALS research · 2013-03-21Clinical Trial Update: Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project
This clinical trial update reports on the outcomes of resin Y-90 microsphere radioembolization for metastatic colorectal cancer with liver m…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating progression-free survival in advanced colorectal cancer patients treated with AMT2003 has been termina…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery [Phase 3]
A Phase 3 trial comparing the timing of combination chemotherapy before versus after surgery for colorectal cancer with resectable liver met…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Phase 3]
Phase 3 trial of oxaliplatin and capecitabine with or without hepatic arterial infusion of floxuridine in patients undergoing surgery or abl…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]
Phase 2 trial evaluating the combination of capecitabine, oxaliplatin, and bevacizumab in metastatic or recurrent colorectal cancer; results…
-
CLINICAL_TRIALS withdrawal · 2013-03-13Clinical Trial Update: Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines [Phase 3]
This Phase 3 trial evaluating second-line FOLFOX with or without regorafenib in metastatic colorectal cancer after failure of first-line iri…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay
The document reports completion of a clinical trial evaluating the performance of Micromedic's CD24 in Vitro Diagnostic Assay for colorectal…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum [Phase 1, Phase 2]
A Phase 1/2 trial evaluating oxaliplatin, capecitabine, and radiation therapy in locally advanced rectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating bevacizumab and cetuximab in combination with FOLFOX6 for metastatic colorectal cancer has completed and…